Lithosphere Deploys MultX to Enable Atomic Cross-Chain Execution on Makalu 
American Aires Inc. Announces Change of Auditor 
Zhibao Technology Announces 1H2026 Earnings Conference Call and Investor Webinar Participation 
Integrated Quantum Technologies Announces Non-Brokered Private Placement of Units 
TechCon Global Announces Dr. Irwin Jacobs as Recipient of the TechCon Fellows Lifetime Achievement Award American IRA Discusses a Primer on Self-Directed IRA Investment Options
ASHEVILLE, NC / ACCESSWIRE / March 27, 2021 / What are the Self-Directed IRA investment…
Miami Entrepreneur Juan Munoz Disrupts The Content Marketing Landscape With Video Advertising
WESTON, FL / ACCESSWIRE / March 27, 2021 / Juan Munoz is disrupting the world…
Greatway Financial Announces the Publication of New Blog Article
Canadian MGA Greatway Financial has announced the publication of a recent blog article which covers…
AgraFlora Announces AGM Voting Results
VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or…
DBV Technologies Announces a New Chair of its Audit Committee and Date of its Annual General Meeting
Montrouge, France, March 26, 2021 DBV Technologies Announces a New Chair of its Audit Committee…
Kraig Biocraft Laboratories Secures $4 Million Dollars of Expansion Capital
ANN ARBOR, Mich., March 26, 2021 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., March 26, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in…
Tauriga Sciences Inc. Announces Upcoming Commercial Launch of its Enhanced, 25mg CBD & CBG Infused, Version of Tauri-Gum
NEW YORK, NY, March 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG)…
Phase 2b VITAL study of Gemogenovatucel-T (Vigil™) immunotherapy demonstrates clinical benefit in homologous recombination (HR) proficient ovarian cancer
Results from pre-planned subgroup analysis of stage III/IV newly diagnosed ovarian cancer patients with BRCA…
OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update
Major expansion of clinical portfolio including initiation of clinical trials with Tedopi® in ovarian cancer,…
BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site
MAINZ, GERMANY, March 26, 2021 (GLOBE NEWSWIRE) — BioNTech SE today announced that the European Medicines…
Bavarian Nordic A/S – Articles of Association
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic – Articles of Association
EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
New stability data show vaccine can be stored at -25°C to -15°C for a total…
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
COPENHAGEN, Denmark, March 26, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
Arcutis Announces Updates to its Executive Team
Scott Burrows to succeed John Smither as Chief Financial Officer (CFO) upon Mr. Smither’s retirement…
Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay
TORONTO, March 26, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA:…
Longeveron Schedules 2020 Fiscal Year End Business Update Conference Call
MIAMI, March 26, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Corrected: Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
MINNEAPOLIS, March 26, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), is re-issuing this…
180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics
NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF)…
GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treatment of COVID-19
LONDON and SAN FRANCISCO, March 26, 2021 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and…